|
14.3% Return Seen to Date on SmarTrend Genomic Health Call (GHDX)
Dec 31, 2012 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend identified a Downtrend for Genomic Health (NASDAQ:GHDX) on October 23rd, 2012 at $31.80. In approximately 2 months, Genomic Health has returned 14.29% as of today's recent price of $27.25.
Over the past year, Genomic Health has traded in a range of $19.00 to $37.44 and is now at $27.25, 43% above that low. The 200-day and 50-day moving averages have moved 0.23% lower and 1.68% lower over the past week, respectively.
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Genomic Health.
Log in and add Genomic Health (GHDX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
